Prab: CSV import

2025-02-13T03:35:19Z

CSV import

← Older revision		Revision as of 03:35, 13 February 2025
Line 1:		Line 1:
	~~'''~~Inogatran''' is a [[pharmaceutical drug]] that belongs to the class of [[anticoagulant]] medications. It is primarily used to prevent and treat [[thrombosis]], a condition characterized by the formation of blood clots within a blood vessel.		== Inogatran ==

	~~==Pharmacology==~~		[[File:Inogatran.svg\|thumb\|right\|Chemical structure of Inogatran]]
	~~Inogatran acts by inhibiting the activity of~~ [[~~thrombin]], an enzyme that plays a crucial role in the process of [[blood clotting]]~~. ~~By blocking the action~~ of ~~thrombin,~~ Inogatran ~~prevents the conversion of [[fibrinogen~~]] ~~to [[fibrin]], thereby inhibiting the formation of blood clots.~~

	~~==Clinical Use==~~		'''Inogatran''' is a synthetic [[anticoagulant]] that functions as a direct [[thrombin]] inhibitor. It is primarily used in the prevention and treatment of [[thromboembolic disorders]].
	Inogatran is ~~used in the prevention and treatment of various conditions associated with thrombosis. These include [[deep vein thrombosis]] (DVT),~~ [[~~pulmonary embolism~~]] ~~(PE), and~~ [[~~stroke~~]]. It is ~~also~~ used in ~~patients with~~ [[~~atrial fibrillation~~]] ~~to reduce the risk of stroke~~.

	==~~Side Effects~~==		=== Mechanism of Action ===
	~~Like all medications,~~ Inogatran ~~can cause side effects. The most common side effects include bleeding,~~ [[~~anemia~~]], ~~and~~ [[~~bruising~~]]. ~~Less common side effects include~~ [[~~allergic reactions~~]], [[~~liver damage~~]], ~~and~~ [[~~thrombocytopenia~~]]~~, a condition characterized by low platelet count~~.		Inogatran works by directly inhibiting the activity of [[thrombin]], an enzyme that plays a central role in the [[coagulation cascade]]. By binding to the active site of thrombin, Inogatran prevents the conversion of [[fibrinogen]] to [[fibrin]], thereby inhibiting the formation of [[blood clots]].

	==~~Contraindications~~==		=== Pharmacokinetics ===
	Inogatran is ~~contraindicated~~ in ~~patients with severe~~ [[liver ~~disease~~]], [[~~kidney disease~~]]~~, and in those who have a known hypersensitivity to the drug~~. ~~It is also contraindicated~~ in ~~pregnant women due to the risk of bleeding~~.		Inogatran is administered [[intravenously]] and has a rapid onset of action. It is metabolized in the [[liver]] and excreted primarily through the [[kidneys]]. The half-life of Inogatran allows for convenient dosing schedules in clinical settings.

	==~~Interactions~~==		=== Clinical Uses ===
	Inogatran ~~can interact with other medications~~, including ~~other anticoagulants,~~ [[~~antiplatelet drugs~~]]~~, and certain~~ [[~~antibiotics~~]]. ~~These interactions can increase~~ the risk of ~~bleeding~~.		Inogatran is used in various clinical scenarios, including:
			* Prevention of [[deep vein thrombosis]] (DVT) in patients undergoing major [[orthopedic surgery]].
			* Treatment of [[pulmonary embolism]] (PE).
			* Management of patients with [[atrial fibrillation]] to reduce the risk of [[stroke]].

	==~~See Also~~==		=== Side Effects ===
			Common side effects of Inogatran include:
			* [[Bleeding]] complications, which are the most significant risk associated with its use.
			* [[Nausea]] and [[vomiting]].
			* [[Hypotension]] in some patients.

			=== Contraindications ===
			Inogatran should not be used in patients with:
			* Active [[bleeding disorders]].
			* Severe [[renal impairment]].
			* Known hypersensitivity to the drug.

			=== Comparison with Other Anticoagulants ===
			Inogatran is part of a class of drugs known as direct thrombin inhibitors, which also includes agents like [[dabigatran]] and [[argatroban]]. Compared to [[warfarin]], Inogatran has a more predictable pharmacokinetic profile and does not require regular [[INR]] monitoring.

			== Related Pages ==
			* [[Thrombin]]
	* [[Anticoagulant]]		* [[Anticoagulant]]
	* [[~~Thrombosis~~]]		* [[Coagulation]]
	* [[Deep vein thrombosis]]		* [[Deep vein thrombosis]]
	* [[Pulmonary embolism]]		* [[Pulmonary embolism]]
	* [[Stroke]]
	* [[Atrial fibrillation]]

	~~[[Category:Pharmaceutical drugs]]~~
	[[Category:Anticoagulants]]		[[Category:Anticoagulants]]
	~~[[Category:Thrombosis]]~~
	~~{{Pharma-stub}}~~
	~~{{Medicine-stub}}~~

Prab: CSV import

2024-02-29T05:05:57Z

CSV import

New page

'''Inogatran''' is a [[pharmaceutical drug]] that belongs to the class of [[anticoagulant]] medications. It is primarily used to prevent and treat [[thrombosis]], a condition characterized by the formation of blood clots within a blood vessel.

==Pharmacology==
Inogatran acts by inhibiting the activity of [[thrombin]], an enzyme that plays a crucial role in the process of [[blood clotting]]. By blocking the action of thrombin, Inogatran prevents the conversion of [[fibrinogen]] to [[fibrin]], thereby inhibiting the formation of blood clots.

==Clinical Use==
Inogatran is used in the prevention and treatment of various conditions associated with thrombosis. These include [[deep vein thrombosis]] (DVT), [[pulmonary embolism]] (PE), and [[stroke]]. It is also used in patients with [[atrial fibrillation]] to reduce the risk of stroke.

==Side Effects==
Like all medications, Inogatran can cause side effects. The most common side effects include bleeding, [[anemia]], and [[bruising]]. Less common side effects include [[allergic reactions]], [[liver damage]], and [[thrombocytopenia]], a condition characterized by low platelet count.

==Contraindications==
Inogatran is contraindicated in patients with severe [[liver disease]], [[kidney disease]], and in those who have a known hypersensitivity to the drug. It is also contraindicated in pregnant women due to the risk of bleeding.

==Interactions==
Inogatran can interact with other medications, including other anticoagulants, [[antiplatelet drugs]], and certain [[antibiotics]]. These interactions can increase the risk of bleeding.

==See Also==
* [[Anticoagulant]]
* [[Thrombosis]]
* [[Deep vein thrombosis]]
* [[Pulmonary embolism]]
* [[Stroke]]
* [[Atrial fibrillation]]

[[Category:Pharmaceutical drugs]]
[[Category:Anticoagulants]]
[[Category:Thrombosis]]
{{Pharma-stub}}
{{Medicine-stub}}

Inogatran - Revision history

Prab: CSV import

Prab: CSV import